Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gold complex auranofin: new perspectives for cancer therapy
Farah H. Abdalbari, Carlos M. Telleria
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 97
Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway
Junbing Zhang, Claire Simpson, Jacqueline Berner, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2361-2379.e25
Closed Access | Times Cited: 91
A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies
Suman Adhikari, Priyatosh Nath, Alakesh Das, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116211-116211
Open Access | Times Cited: 62
Metal N-heterocyclic carbene complexes as potential metallodrugs in antitumor therapy
Yifan Zhang, Yi-Kui Yin, Heng Zhang, et al.
Coordination Chemistry Reviews (2024) Vol. 514, pp. 215941-215941
Closed Access | Times Cited: 15
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 55
Glutathione S-transferase: A versatile and dynamic enzyme
Chinyere Aloke, Olalekan Onisuru, Ikechukwu Achilonu
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150774-150774
Closed Access | Times Cited: 10
Gold(I) N‐heterocyclic carbene (NHC) complexes containing 6‐mercaptopurine derivatives and their in vitro anticancer and anti‐inflammatory effects
Zdeněk Trávnı́ček, Ján Vančo, Michal Čajan, et al.
Applied Organometallic Chemistry (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 9
Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis
Raffaele Sciaccotta, Sebastiano Gangemi, Giuseppa Penna, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 475-475
Open Access | Times Cited: 8
The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy
Wenyue Yang, Zhou Zhu, Chaohua Zhou, et al.
Free Radical Biology and Medicine (2025)
Closed Access | Times Cited: 1
Selective cellular probes for mammalian thioredoxin reductase TrxR1: Rational design of RX1, a modular 1,2-thiaselenane redox probe
Lukas Zeisel, Jan G. Felber, Karoline Scholzen, et al.
Chem (2022) Vol. 8, Iss. 5, pp. 1493-1517
Open Access | Times Cited: 34
Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases
Radosveta Gencheva, Qing Cheng, Elias S.J. Arnér
Free Radical Biology and Medicine (2022) Vol. 190, pp. 320-338
Open Access | Times Cited: 29
Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications
Ning Lv, Chunyan Huang, Haoyan Huang, et al.
Antioxidants (2023) Vol. 12, Iss. 11, pp. 1970-1970
Open Access | Times Cited: 19
Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer
Ana Luísa De Sousa‐Coelho, Gil Fraqueza, Manuel Aureliano
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 12-12
Open Access | Times Cited: 17
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity
Annaluisa Mariconda, Domenico Iacopetta, Marco Sirignano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2599-2599
Open Access | Times Cited: 7
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
Huzaifa Yasir Khan, Mohammad Fawad Ansari, Sartaj Tabassum, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104055-104055
Closed Access | Times Cited: 7
Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency
Yaron Marciano, Virginia del Solar, Nazia Nayeem, et al.
Journal of the American Chemical Society (2022) Vol. 145, Iss. 1, pp. 234-246
Closed Access | Times Cited: 26
Selenoproteins and tRNA-Sec: regulators of cancer redox homeostasis
Stephen L. DeAngelo, Balázs Győrffy, Markos Koutmos, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1006-1018
Closed Access | Times Cited: 15
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer
Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity
Chandra Bhushan Prasad, Adrian Oo, Yujie Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Gold(I) N-heterocyclic carbene complexes show strong proapoptotic, antioxidant and anti-inflammatory effects in A2780 and endothelial cells
Zdeněk Trávnı́ček, Ján Vančo, Michal Čajan, et al.
Chemico-Biological Interactions (2025) Vol. 408, pp. 111381-111381
Closed Access
Mitoregulin Promotes Cell Cycle Progression in Non-Small Cell Lung Cancer Cells
Colleen S. Stein, Connor R. Linzer, Collin D. Heer, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1939-1939
Open Access
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments
Ester Giorgi, Francesca Binacchi, Carlo Marotta, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 273-273
Open Access | Times Cited: 20
Organometallic gold(I) and gold(III) complexes for lung cancer treatment
Juzheng Zhang, Yanping Li, Ronghao Fang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers
Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 667-667
Open Access | Times Cited: 12
Bioconjugation of the gold drug auranofin to human ferritin yields a potent cytotoxin
Lucrezia Cosottini, Lara Massai, Veronica Ghini, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104822-104822
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top